Luminopia logo — Pioneering a new class of treatments for significant neuro-v...

Luminopia

Pioneering a new class of treatments for significant neuro-visual disorders.

Founded 2016 United States Cambridge, United States 24 employees Series A Total: $33.15M Health Care, VR/AR

General Information

Company Name Luminopia
Founded Year 2016
Location United States Cambridge, United States
Employees 24
Industries Health Care, VR/AR
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Luminopia. To contact Luminopia, visit luminopia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Luminopia

Luminopia is a startup focused on pioneering a new class of treatments for significant neuro-visual disorders. Founded in 2015, the company is committed to developing digital therapeutics evaluated for FDA approval and engaging for patients. Luminopia's collaboration with Boston Children’s Hospital as an Innovation Partner emphasizes its dedication to innovation in healthcare. The company's primary focus is on developing a lead product to address amblyopia, the leading cause of vision loss among children. With a recent $16.00M Series A investment on 27 June 2023, Luminopia secured funding from prominent investors including US Venture Partners, The Vertical Group, ShangBay Capital, and Broadfin Advisors. Operating at the convergence of Health Care and VR/AR industries, Luminopia is positioning itself as a compelling player in the digital therapeutics space. For more details, visit luminopia.com.

Taxonomy: digital therapeutics, neuro-visual disorders, FDA approval, amblyopia treatment, pediatric vision care, vision loss, innovation partnership, Boston Children's Hospital, healthtech, ophthalmology, neuroscience

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $16.00M 4
US Venture Partners, The Vertical Group +2
27 Jun 2023
Seed Round $5.70M 4
The Vertical Group, ShangBay Capital +2
11 Nov 2022
Seed Round $4.83M 1
NXT Ventures
01 Mar 2020
Pre Seed Round $5.68M 1
Bantam Group
01 Nov 2019
Angel Round $950.00K -
01 Oct 2016

Luminopia Alternatives & Competitors

Luminopia vs
RemmedVR
RemmedVR United States

Doctor supervised, VR based, vision therapy for home use.

Non Equity Assistance
4 employees
Health Care, Information Technology
Luminopia vs
Smileyscope
Smileyscope Australia

Improving needle experiences through innovative virtual reality technology

Seed
16 employees
Health Care, Health and Wellness

FAQ About Luminopia

Pioneering a new class of treatments for significant neuro-visual disorders.
Luminopia was founded in 2016.
Luminopia is headquartered in Cambridge, United States.
Luminopia operates in Health Care and VR/AR. Its work centres on digital therapeutics, neuro-visual disorders, FDA approval and amblyopia treatment.
Luminopia has approximately 24 employees.
Luminopia has completed 5 funding rounds, raising a total of $33.15M. The latest funding stage is Series A.
Top alternatives and competitors to Luminopia include RemmedVR, Smileyscope. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Luminopia and RemmedVR are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Luminopia, https://bouncewatch.com/company/luminopia, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes